Spots Global Cancer Trial Database for pathological response rate
Every month we try and update this database with for pathological response rate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer. | NCT00933517 | Pathological Re... | vectibix fluorouracile Epirubicine cyclophosphamid... docetaxel | 18 Years - | Centre Jean Perrin | |
Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer. | NCT00933517 | Pathological Re... | vectibix fluorouracile Epirubicine cyclophosphamid... docetaxel | 18 Years - | Centre Jean Perrin |